Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Galirayo who wrote (1222)	7/15/2005 1:22:28 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

AEGN Seems to have found support at the $0.40 level. The insiders have continued to sell.<g> But on the 1stQ the revenues were up 49% and the loss was cut from $1.21/shr in 2004 to $0.13/shr. On the June Q it had a loss of $2.05/shr in 2004 and it seems probable that it will sow also a good comparison when the results are available. AEGN reportedly has around $1.80 in cash/shr and no significant LTD THere are 7.37M shares out but the insiders hold more than 15%. The float is around 4M THe stock is up around 15% today and its long term chart remains "interesting".<g> bigcharts.marketwatch.com Bernard